Cargando…
Randomized Interventional Study on Prediction of Preeclampsia/Eclampsia in Women With Suspected Preeclampsia: INSPIRE
The ratio of maternal serum sFlt-1 (soluble fms-like tyrosine kinase 1) to PlGF (placental growth factor) has been used retrospectively to rule out the occurrence of preeclampsia, a pregnancy hypertensive disorder, within 7 days in women presenting with clinical suspicion of preeclampsia. A prospect...
Autores principales: | Cerdeira, Ana Sofia, O’Sullivan, Joe, Ohuma, Eric O., Harrington, Deborah, Szafranski, Pawel, Black, Rebecca, Mackillop, Lucy, Impey, Lawrence, Greenwood, Catherine, James, Tim, Smith, Ian, Papageorghiou, Aris T., Knight, Marian, Vatish, Manu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott, Williams & Wilkins
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756298/ https://www.ncbi.nlm.nih.gov/pubmed/31401877 http://dx.doi.org/10.1161/HYPERTENSIONAHA.119.12739 |
Ejemplares similares
-
The prognostic utility of soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PIGF) biomarkers for predicting preeclampsia: a secondary analysis of data from the INSPIRE trial
por: Kifle, Meron M., et al.
Publicado: (2022) -
Preeclampsia-Eclampsia Adverse Outcomes Reduction: The Preeclampsia-Eclampsia Checklist
por: Nwanodi, Oroma B.
Publicado: (2016) -
Preeclampsia - Eclampsia : nuevo enfoque de tratamiento
por: Aparicio Sosa, Patricia
Publicado: (1999) -
Preeclampsia and syncytiotrophoblast membrane extracellular vesicles (STB-EVs)
por: Awoyemi, Toluwalase, et al.
Publicado: (2022) -
RAS in Pregnancy and Preeclampsia and Eclampsia
por: Rodriguez, M., et al.
Publicado: (2012)